Suppr超能文献

宫颈癌研究中的类器官技术。

Organoid technology in cervical cancer research.

作者信息

Ye Hui, Song Liang, Li Qingli, Shen Chongyang, He Yuedong, Li Lin

机构信息

Department of Gynecology, West China Second University Hospital, Sichuan University Chengdu 610041, Sichuan, China.

Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education Chengdu 610041, Sichuan, China.

出版信息

Am J Cancer Res. 2025 May 15;15(5):1988-2003. doi: 10.62347/FNTD1712. eCollection 2025.

Abstract

Cervical cancer poses a serious threat to women's lives and health, and it may cause damage to the reproductive system, infertility, and even death. This study reviews the research progress of organoids in the treatment of cervical cancer. Studies have found that the culturing of tumor cell lines and the modeling techniques of tumor xenotransplantation for cervical cancer have certain limitations. Cervical cancer organoids are preclinical research models formed by culturing tumor cells derived from patients, which more accurately and effectively retain tumor heterogeneity, and also have the potential to take into account the interaction between tumor cells and the extracellular matrix. This article reviews the research on cervical cancer organoid models in the pathogenesis, drug screening, and precision medicine aspects in recent years, and then analyzes the development prospects and challenges of organoid technology in gynecological tumor research, in order to explore new possibilities for individualized treatment of cervical cancer.

摘要

宫颈癌对女性的生命和健康构成严重威胁,可能会对生殖系统造成损害、导致不孕,甚至死亡。本研究综述了类器官在宫颈癌治疗中的研究进展。研究发现,宫颈癌的肿瘤细胞系培养及肿瘤异种移植建模技术存在一定局限性。宫颈癌类器官是通过培养患者来源的肿瘤细胞形成的临床前研究模型,能更准确有效地保留肿瘤异质性,还具有兼顾肿瘤细胞与细胞外基质间相互作用的潜力。本文综述了近年来宫颈癌类器官模型在发病机制、药物筛选和精准医学方面的研究,进而分析类器官技术在妇科肿瘤研究中的发展前景与挑战,以期探索宫颈癌个体化治疗的新可能。

相似文献

1
Organoid technology in cervical cancer research.
Am J Cancer Res. 2025 May 15;15(5):1988-2003. doi: 10.62347/FNTD1712. eCollection 2025.
2
Advances in the application of colorectal cancer organoids in precision medicine.
Front Oncol. 2024 Dec 3;14:1506606. doi: 10.3389/fonc.2024.1506606. eCollection 2024.
4
Organoid modeling meets cancers of female reproductive tract.
Cell Death Discov. 2024 Sep 27;10(1):410. doi: 10.1038/s41420-024-02186-x.
5
Application and prospect of organoid technology in breast cancer.
Front Immunol. 2024 Aug 26;15:1413858. doi: 10.3389/fimmu.2024.1413858. eCollection 2024.
6
Organoid development and applications in gynecological cancers: the new stage of tumor treatment.
J Nanobiotechnology. 2025 Jan 16;23(1):20. doi: 10.1186/s12951-024-03086-z.
7
Current applications, future Perspectives and challenges of Organoid technology in oral cancer research.
Eur J Pharmacol. 2025 Apr 15;993:177368. doi: 10.1016/j.ejphar.2025.177368. Epub 2025 Feb 11.
8
Novel organoid model in drug screening: Past, present, and future.
Liver Res. 2021 May 27;5(2):72-78. doi: 10.1016/j.livres.2021.05.003. eCollection 2021 Jun.
9
Recent advances in patient-derived tumor organoids for reconstructing TME of head and neck cancer.
J Oral Pathol Med. 2024 Apr;53(4):238-245. doi: 10.1111/jop.13532. Epub 2024 Apr 1.
10
Toward reproducible tumor organoid culture: focusing on primary liver cancer.
Front Immunol. 2024 Mar 20;15:1290504. doi: 10.3389/fimmu.2024.1290504. eCollection 2024.

本文引用的文献

1
Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancer.
Phys Imaging Radiat Oncol. 2024 Apr 13;30:100578. doi: 10.1016/j.phro.2024.100578. eCollection 2024 Apr.
2
Progress and breakthroughs in human kidney organoid research.
Biochem Biophys Rep. 2024 Jun 3;39:101736. doi: 10.1016/j.bbrep.2024.101736. eCollection 2024 Sep.
3
Considerations for route of hysterectomy in low-risk cervical cancer.
Int J Gynecol Cancer. 2024 Sep 2;34(9):1481. doi: 10.1136/ijgc-2024-005745.
5
Modeling of the brain-lung axis using organoids in traumatic brain injury: an updated review.
Cell Biosci. 2024 Jun 22;14(1):83. doi: 10.1186/s13578-024-01252-2.
7
The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers.
BMC Womens Health. 2024 Jun 22;24(1):365. doi: 10.1186/s12905-024-03215-8.
8
The activation of Piezo1 channel promotes invasion and migration via the release of extracellular ATP in cervical cancer.
Pathol Res Pract. 2024 Aug;260:155426. doi: 10.1016/j.prp.2024.155426. Epub 2024 Jun 20.
9
RNA Isolation from Human Stem Cell-Derived Retinal Organoids.
Methods Mol Biol. 2024;2822:3-11. doi: 10.1007/978-1-0716-3918-4_1.
10
Barriers to and opportunities for advancing racial equity in cervical cancer screening in the United States.
BMC Womens Health. 2024 Jun 21;24(1):362. doi: 10.1186/s12905-024-03151-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验